Overall rank by patents
#23,489
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
According to USPTO PatentsView, Swift ranks #23,489 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R23489 · US Corporation #23,489 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Salflex Polymers Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Swift Biosciences · this assignee
28 score
3D Lighting Innovati… · lowest
7 score
What this shows Swift's Innovation Score is 28.2/100 (top 73% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Swift Biosciences, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2018. By volume, Swift sits between Surgical Innovation Associates, Inc. and Sandisk Semiconductor (shanghai) Co. Ltd..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SURGICAL INNOVATION ASSOCIATES, INC.
12 patents
SUZHOU CLEVA ELECTRIC APPLIANCE CO., LTD
12 patents
SUZHOU MICROPORT ORTHOBOT CO., LTD.
12 patents
SUZHOU RADIANT PHOTOVOLTAIC TECHNOLOGY CO., LTD.
12 patents
SWM International, LLC
12 patents
SYNTORR INC.
12 patents
Salflex Polymers Limited
12 patents
SanDisk Semiconductor (Shanghai) Co. Ltd.
12 patents
SWIFT BIOSCIENCES, INC.
12 patents
What this shows Swift holds 12 patents at rank #23,407, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,407 in granted patent volume.
Other assignees with the most granted patents in Swift's primary technology class.
Swift's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 Top 73% higher than 27% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 8.3% |
| 2019 | 5 | 41.7% |
| 2020 | 1 | 8.3% |
| 2021 | 4 | 33.3% |
| 2022 | 1 | 8.3% |
Top 5 of 5 technology areas
Overall rank by patents
#23,489
of 50,000 tracked assignees
28.2 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.